Novel Breakthroughs in Management of Pediatric Low-Grade Glioma (pLGG) - Episode 5

Ongoing clinical trials for frontline treatment of non-V600E-specific pLGG tumors

The panel reviews ongoing clinical trials for non-BRAF V600E pediatric low-grade gliomas (pLGG), specifically highlighting the Phase III ACNS1831 and Phase III ACNS1833 studies, discussing their objectives, designs, and potential implications for future treatment strategies.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    • What are some ongoing Phase II/III trials in this space?
      • Phase II Vinblastine +/- Bevacizumab in chemotherapy naïve pLGG (NCT02840409)
      • Phase III ACNS1831: Selumetinib vs carboplatin/vincristine in NF1 pLGG (NCT03871257)
      • Phase III ACNS1833: Selumetinib vs carboplatin/vincristine in non-V600E and non-NF1 pLGG (NCT04166409)

    x